Lai Wei
#131,094
Most Influential Person Now
Lai Wei's AcademicInfluence.com Rankings
Lai Weiphilosophy Degrees
Philosophy
#6368
World Rank
#9396
Historical Rank
Logic
#3545
World Rank
#4725
Historical Rank
Download Badge
Philosophy
Lai Wei's Degrees
- PhD Biomedical Sciences University of California, San Francisco
- Doctorate Medicine Stanford University
Why Is Lai Wei Influential?
(Suggest an Edit or Addition)Lai Wei's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- American association for the study of liver diseases (1992) (2586)
- Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030. (2018) (881)
- Epidemiologic and Clinical Characteristics of Novel Coronavirus Infections Involving 13 Patients Outside Wuhan, China. (2020) (603)
- Guideline of Prevention and Treatment for Chronic Hepatitis B (2015 Update) (2017) (276)
- APASL consensus statements and recommendation on treatment of hepatitis C (2016) (193)
- CSH guidelines for the diagnosis and treatment of drug-induced liver injury (2017) (178)
- Telbivudine versus lamivudine in Chinese patients with chronic hepatitis B: Results at 1 year of a randomized, double‐blind trial (2007) (166)
- APASL consensus statements and management algorithms for hepatitis C virus infection (2012) (166)
- Peritumoural neutrophils negatively regulate adaptive immunity via the PD-L1/PD-1 signalling pathway in hepatocellular carcinoma (2015) (156)
- [Introduction and comments on EASL clinical practice guidelines: management of hepatitis C virus infection]. (2011) (145)
- Palmitoleate Induces Hepatic Steatosis but Suppresses Liver Inflammatory Response in Mice (2012) (123)
- MicroRNAs‐372/373 promote the expression of hepatitis B virus through the targeting of nuclear factor I/B (2011) (116)
- Distribution and clinical correlates of viral and host genotypes in Chinese patients with chronic hepatitis C virus infection (2014) (114)
- Interferons Accelerate Decay of Replication-Competent Nucleocapsids of Hepatitis B Virus (2010) (113)
- Hepatic steatosis in chronic hepatitis B patients is associated with metabolic factors more than viral factors (2008) (105)
- In vitro inhibition of HBV replication by a novel compound, GLS4, and its efficacy against adefovir-dipivoxil-resistant HBV mutations (2012) (99)
- STING Agonists Induce an Innate Antiviral Immune Response against Hepatitis B Virus (2014) (96)
- HBV core protein allosteric modulators differentially alter cccDNA biosynthesis from de novo infection and intracellular amplification pathways (2017) (90)
- aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis. (2020) (87)
- Hepatic differentiation capability of rat bone marrow-derived mesenchymal stem cells and hematopoietic stem cells. (2004) (86)
- Guidelines of prevention and treatment of nonalcoholic fatty liver disease (2018, China) (2018) (85)
- APASL consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing (2016) (83)
- A review of the burden of hepatitis C virus infection in China, Japan, South Korea and Taiwan (2015) (82)
- Antiviral activities of ISG20 in positive-strand RNA virus infections (2010) (82)
- Expression of cancer/testis (CT) antigens in Chinese hepatocellular carcinoma and its correlation with clinical parameters. (2005) (78)
- Sofosbuvir-velpatasvir for treatment of chronic hepatitis C virus infection in Asia: a single-arm, open-label, phase 3 trial. (2019) (77)
- Relationship between hepatitis B virus DNA levels and liver histology in patients with chronic hepatitis B. (2007) (74)
- Genotype B and younger patient age associated with better response to low-dose therapy: a trial with pegylated/nonpegylated interferon-alpha-2b for hepatitis B e antigen-positive patients with chronic hepatitis B in China. (2007) (74)
- Prevalence of Type 2 Diabetes among Newly Detected Pulmonary Tuberculosis Patients in China: A Community Based Cohort Study (2013) (69)
- APASL HCV guidelines of virus-eradicated patients by DAA on how to monitor HCC occurrence and HBV reactivation (2019) (65)
- Survey of hepatitis B knowledge and stigma among chronically infected patients and uninfected persons in Beijing, China (2016) (59)
- [The guideline of prevention and treatment for hepatitis C: a 2015 update]. (2015) (56)
- Impact of new hepatitis C treatments in different regions of the world. (2014) (56)
- Targeted Overexpression of Inducible 6-Phosphofructo-2-kinase in Adipose Tissue Increases Fat Deposition but Protects against Diet-induced Insulin Resistance and Inflammatory Responses* (2012) (54)
- STING expression in monocyte-derived macrophages is associated with the progression of liver inflammation and fibrosis in patients with nonalcoholic fatty liver disease (2019) (54)
- The Chinese Society of Hepatology position statement on the redefinition of fatty liver disease. (2021) (53)
- Quantitative serum HBsAg and HBeAg are strong predictors of sustained HBeAg seroconversion to pegylated interferon alfa‐2b in HBeAg‐positive patients (2010) (52)
- Hematopoietic stem cells mobilized by granulocyte colony‐stimulating factor partly contribute to liver graft regeneration after partial orthotopic liver transplantation (2006) (48)
- Management Algorithm for Interrupting Mother to Child Transmission of Hepatitis B Virus. (2019) (48)
- BST2/Tetherin Inhibits Dengue Virus Release from Human Hepatoma Cells (2012) (47)
- qFIBS: An Automated Technique for Quantitative Evaluation of Fibrosis, Inflammation, Ballooning, and Steatosis in Patients With Nonalcoholic Steatohepatitis (2020) (47)
- Up-regulation of interleukin-22 mediates liver fibrosis via activating hepatic stellate cells in patients with hepatitis C. (2015) (46)
- Current Challenges and the Management of Chronic Hepatitis C in Mainland China (2014) (45)
- Genetic variation in IL28B is associated with the development of hepatitis B-related hepatocellular carcinoma (2012) (44)
- FOXP3 gene polymorphism is associated with hepatitis B-related hepatocellular carcinoma in China (2013) (43)
- Regulatory T cell depletion enhances tumor specific CD8 T-cell responses, elicited by tumor antigen NY-ESO-1b in hepatocellular carcinoma patients, in vitro. (2010) (42)
- Outcomes of Long-term Treatment of Chronic HBV Infection With Entecavir or Other Agents From a Randomized Trial in 24 Countries. (2020) (42)
- Association of interleukin-12 p40 gene 3'-untranslated region polymorphism and outcome of HCV infection. (2004) (41)
- Effect of abstinence from alcohol on survival of patients with alcoholic cirrhosis: A systematic review and meta‐analysis (2014) (41)
- Transplanted endothelial progenitor cells ameliorate carbon tetrachloride–induced liver cirrhosis in rats (2009) (41)
- Effect of interferon-alpha-based antiviral therapy on hepatitis C virus-associated glomerulonephritis: a meta-analysis. (2012) (40)
- Chinese guidelines on the management of ascites and its related complications in cirrhosis (2019) (39)
- Performance Comparison of the Versant HCV Genotype 2.0 Assay (LiPA) and the Abbott Realtime HCV Genotype II Assay for Detecting Hepatitis C Virus Genotype 6 (2014) (39)
- SARS-CoV Nucleocapsid Protein Induced Apoptosis of COS-1 Mediated by the Mitochondrial Pathway (2007) (37)
- BST2/Tetherin inhibits hepatitis C virus production in human hepatoma cells. (2013) (37)
- Etiology and Clinical Characteristics of Influenza-Like Illness (ILI) in Outpatients in Beijing, June 2010 to May 2011 (2012) (35)
- Absolute quantification of serum microRNA-122 and its correlation with liver inflammation grade and serum alanine aminotransferase in chronic hepatitis C patients. (2015) (35)
- Will Sofosbuvir/Ledipasvir (Harvoni) Be Cost-Effective and Affordable for Chinese Patients Infected with Hepatitis C Virus? An Economic Analysis Using Real-World Data (2016) (35)
- Response-guided peginterferon therapy in patients with HBeAg-positive chronic hepatitis B: A randomized controlled study. (2016) (33)
- Etiological analysis and predictive diagnostic model building of community-acquired pneumonia in adult outpatients in Beijing, China (2013) (33)
- A phase 3, open‐label study of daclatasvir plus asunaprevir in Asian patients with chronic hepatitis C virus genotype 1b infection who are ineligible for or intolerant to interferon alfa therapies with or without ribavirin (2016) (32)
- Serum HBV core‐related antigen is a good predictor for spontaneous HBeAg seroconversion in chronic hepatitis B patients (2017) (32)
- Inhibition of Hepatitis B Virus Replication by Bay 41-4109 and Its Association with Nucleocapsid Disassembly (2008) (32)
- Chinese guidelines on the management of liver cirrhosis (abbreviated version) (2020) (31)
- Serum viral duplex-linear DNA proportion increases with the progression of liver disease in patients infected with HBV (2015) (30)
- The Lumipulse G HBsAg-Quant assay for screening and quantification of the hepatitis B surface antigen. (2016) (30)
- Noninvasive Measurements Predict Liver Fibrosis Well in Hepatitis C Virus Patients After Direct-Acting Antiviral Therapy (2019) (29)
- APASL clinical practice recommendation: how to treat HCV-infected patients with renal impairment? (2018) (29)
- Detection of residual HCV-RNA in patients who have achieved sustained virological response is associated with persistent histological abnormality (2019) (28)
- Efficacy and safety of elbasvir/grazoprevir in participants with hepatitis C virus genotype 1, 4, or 6 infection from the Asia–Pacific region and Russia: Final results from the randomized C‐CORAL study (2018) (28)
- In vitro resistance to interferon of hepatitis B virus with precore mutation. (2005) (27)
- Clinical and Molecular epidemiologic analyses of norovirus‐associated sporadic gastroenteritis in adults from Beijing, China (2011) (27)
- Real‐world treatment patterns and clinical outcomes of HCV treatment‐naive patients in China: an interim analysis from the CCgenos study (2017) (26)
- Outcome of hepatitis C virus infection in Chinese paid plasma donors: A 12–19‐year cohort study (2012) (26)
- A cross-sectional assessment of health-related quality of life in Chinese patients with chronic hepatitis c virus infection with EQ-5D (2018) (26)
- Automated evaluation of liver fibrosis in thioacetamide, carbon tetrachloride, and bile duct ligation rodent models using second-harmonic generation/two-photon excited fluorescence microscopy (2017) (25)
- Senescence marker protein 30 in acute liver failure: validation of a mass spectrometry proteomics assay (2008) (25)
- Proteome responses to stable hepatitis B virus transfection and following interferon alpha treatment in human liver cell line HepG2 (2009) (25)
- Characterization of microRNA expression profiles associated with hepatitis B virus replication and clearance in vivo and in vitro (2012) (24)
- Sequential combination therapy with interferon, interleukin-2 and therapeutic vaccine in entecavir-suppressed chronic hepatitis B patients: the Endeavor study (2019) (24)
- Bone Metastases in Well-to-Moderately Differentiated Neuroendocrine Tumors: A Single Institutional Review From the Ohio State University Medical Center (2015) (24)
- Delivery of cell-penetrating peptide-peptide nucleic acid conjugates by assembly on an oligonucleotide scaffold (2015) (24)
- Molecular epidemiology and evolution of A(H1N1)pdm09 and H3N2 virus during winter 2012-2013 in Beijing, China. (2014) (24)
- The experience of discrimination of individuals living with chronic hepatitis B in four provinces of China (2018) (23)
- Hepatitis E virus infection in acute non-traumatic neuropathy: A large prospective case-control study in China (2018) (23)
- Polymorphisms of interferon-inducible genes OAS associated with interferon-α treatment response in chronic HBV infection. (2011) (23)
- Performance evaluation and comparison of the newly developed Elecsys anti-HCV II assay with other widely used assays. (2013) (22)
- A multicenter, randomized, double-blind trial comparing the efficacy and safety of TUDCA and UDCA in Chinese patients with primary biliary cholangitis (2016) (22)
- Hepatitis B Virus Virions Produced Under Nucleos(t)ide Analogue Treatment Are Mainly Not Infectious Because of Irreversible DNA Chain Termination (2019) (21)
- Clinical and Epidemiologic Characteristics of Norovirus GII.4 Sydney during Winter 2012–13 in Beijing, China following Its Global Emergence (2013) (21)
- Ledipasvir/sofosbuvir for treatment-naive and treatment-experienced Chinese patients with genotype 1 HCV: an open-label, phase 3b study (2018) (21)
- How would China achieve WHO’s target of eliminating HCV by 2030? (2019) (21)
- RO 90-7501 Enhances TLR3 and RLR Agonist Induced Antiviral Response (2012) (21)
- Evaluation of the Elecsys(®) Anti-HCV II assay for routine hepatitis C virus screening of different Asian Pacific populations and detection of early infection. (2015) (21)
- Features of hepatitis C virus infection, current therapies and ongoing clinical trials in ten Asian Pacific countries (2015) (21)
- Molecular epidemiology and evolution of influenza A and B viruses during winter 2013-2014 in Beijing, China (2015) (21)
- Long-Term Telbivudine Treatment Results in Resolution of Liver Inflammation and Fibrosis in Patients with Chronic Hepatitis B (2015) (20)
- The Asian Pacific Association for the Study of the Liver clinical practice guidance: the diagnosis and management of patients with autoimmune hepatitis (2021) (20)
- The transcription factor RFX5 is a transcriptional activator of the TPP1 gene in hepatocellular carcinoma. (2017) (20)
- Effects of Esophageal Acidification on Troublesome Symptoms: An Approach to Characterize True Acid GERD in Dysphagic Neonates (2017) (19)
- HBcrAg Identifies Patients Failing to Achieve HBeAg Seroconversion Treated with Pegylated Interferon Alfa-2b (2016) (19)
- Assay for Hepatitis B Core-related Antigen Identify Patients With High Viral Load: Systematic Review and Meta-analysis of Individual Participant Data. (2020) (19)
- Risk Assessment of Hepatocellular Carcinoma in Patients with Hepatitis C in China and the USA (2017) (18)
- Spontaneous viral clearance after 6-21 years of hepatitis B and C viruses coinfection in high HBV endemic area. (2003) (18)
- DCs Pulsed with Novel HLA-A2-Restricted CTL Epitopes against Hepatitis C Virus Induced a Broadly Reactive Anti-HCV-Specific T Lymphocyte Response (2012) (18)
- In vitro resistance to interferon-alpha of hepatitis B virus with basic core promoter double mutation. (2007) (18)
- Deep sequencing of hepatitis B virus basal core promoter and precore mutants in HBeAg-positive chronic hepatitis B patients (2015) (18)
- Role of ISGF3 in modulating the anti‐hepatitis B virus activity of interferon‐alpha in vitro (2008) (18)
- Antiviral action of interferon‐α against hepatitis C virus replicon and its modulation by interferon‐γ and interleukin‐8 (2007) (17)
- Frequency of T-cell FoxP3⁺ Treg and CD4⁺/CD8⁺ PD-1 expression is related to HBeAg seroconversion in hepatitis B patients on pegylated interferon. (2013) (17)
- Sofosbuvir plus ribavirin with or without peginterferon for the treatment of hepatitis C virus: Results from a phase 3b study in China (2018) (17)
- Hepatitis B virus infection in Chinese patients with hepatitis C virus infection: prevalence, clinical characteristics, viral interactions and host genotypes: a nationwide cross-sectional study (2016) (17)
- Glecaprevir-pibrentasvir to treat chronic hepatitis C virus infection in Asia: two multicentre, phase 3 studies- a randomised, double-blind study (VOYAGE-1) and an open-label, single-arm study (VOYAGE-2). (2020) (17)
- Investment Case for a Comprehensive Package of Interventions Against Hepatitis B in China: Applied Modeling to Help National Strategy Planning (2020) (17)
- Second Harmonic Generation Reveals Subtle Fibrosis Differences in Adult and Pediatric Nonalcoholic Fatty Liver Disease (2017) (16)
- Regulatory factor X5 promotes hepatocellular carcinoma progression by transactivating tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta and suppressing apoptosis (2019) (16)
- Metabonomic analysis of liver tissue from BALB/c mice with d-galactosamine/lipopolysaccharide-induced acute hepatic failure (2013) (16)
- Chinese guidelines on management of hepatic encephalopathy in cirrhosis (2019) (16)
- Sofosbuvir and ledipasvir are associated with high sustained virologic response and improvement of health‐related quality of life in East Asian patients with hepatitis C virus infection (2018) (16)
- [516] A RANDOMIZED TRIAL OF SWITCHING TO TELBIVUDINE VERSUS CONTINUED LAMIVUDINE IN ADULTS WITH CHRONIC HEPATITIS B: RESULTS OF THE PRIMARY ANALYSIS AT WEEK 24 (2007) (16)
- Utility of the EncephalApp Stroop Test for covert hepatic encephalopathy screening in Chinese cirrhotic patients (2019) (16)
- Multicentre evaluation of the Elecsys® hepatitis B surface antigen II assay for detection of HBsAg in comparison with other commercially available assays (2009) (16)
- Artificial recombinant cell-penetrating peptides interfere with envelopment of hepatitis B virus nucleocapsid and viral production. (2011) (15)
- Inhibitory effect of human interferon‐beta‐1a on activated rat and human hepatic stellate cells (2010) (15)
- MYL6B, a myosin light chain, promotes MDM2-mediated p53 degradation and drives HCC development (2018) (15)
- Expression of MAGE-A1 mRNA is associated with gene hypomethylation in hepatocarcinoma cell lines (2005) (15)
- Characteristics of alcoholic liver disease and predictive factors for mortality of patients with alcoholic cirrhosis. (2013) (15)
- A novel scoring system for prognostic prediction in d-galactosamine/lipopolysaccharide-induced fulminant hepatic failure BALB/c mice (2009) (15)
- Long-term outcomes in patients with chronic hepatitis C in the current era of direct-acting antiviral agents (2019) (15)
- An interferon-beta promoter reporter assay for high throughput identification of compounds against multiple RNA viruses (2014) (15)
- Antiviral action of interferon-alpha against hepatitis C virus replicon and its modulation by interferon-gamma and interleukin-8. (2007) (15)
- Inadequate awareness of hepatitis C among nonspecialist physicians in China (2011) (14)
- Awareness and Knowledge of Nonalcoholic Fatty Liver Disease Among Office Employees in Beijing, China (2018) (14)
- Prospective study in 142 cases of hepatitis C virus infection. (2004) (14)
- Incidence and risk factors of hepatocellular carcinoma in patients with hepatitis C in China and the United States (2020) (14)
- Benefits of long-term therapy with nucleos(t)ide analogues in treatment-naïve patients with chronic hepatitis B (2017) (14)
- Nonstructural 5A gene variability of hepatitis C virus (HCV) during a 10-year follow up (2004) (14)
- Prevalence and characterization of hepatitis B and C virus infections in a needle-sharing population in Northern China (2015) (13)
- Direct-acting Antiviral Agents Resistance-associated Polymorphisms in Chinese Treatment-naïve Patients Infected with Genotype 1b Hepatitis C Virus (2015) (13)
- GII.4 Sydney_2012 norovirus infection in immunocompromised patients in Beijing and its rapid evolution in vivo (2016) (13)
- Direct antiviral agents upregulate natural killer cell potential activity in chronic hepatitis C patients (2019) (13)
- HCV phylogenetic signature and prevalence of pretreatment NS5A and NS5B NI‐Resistance associated substitutions in HCV‐Infected patients in Mainland China (2018) (13)
- PPPDE1 is a novel deubiquitinase belonging to a cysteine isopeptidase family. (2017) (13)
- Impact of hepatitis C virus genotype 3 on liver disease progression in a Chinese national cohort (2020) (13)
- [Expression of tumor-specific cancer/testis antigens in hepatocellular carcinoma]. (2003) (13)
- Application of plasma circulating cell-free DNA detection to the molecular diagnosis of hepatocellular carcinoma. (2019) (13)
- Efficacy of Real-world Entecavir Therapy in Treatment-naïve Chronic Hepatitis B Patients (2017) (12)
- The effect of cytokine profiles on the viral response to re-treatment in antiviral-experienced patients with chronic hepatitis C virus infection. (2011) (12)
- A comparative study of patients’ knowledge about hepatitis C in the United States and in urban and rural China (2014) (12)
- Two-year results of a randomized, phase III comparative trial of telbivudine versus lamivudine in Chinese patients (2013) (12)
- A Higher Correlation of HCV Core Antigen with CD4+ T Cell Counts Compared with HCV RNA in HCV/HIV-1 Coinfected Patients (2011) (12)
- Prediction of spontaneous HBeAg seroconversion in HBeAg‐positive chronic hepatitis B patients during the immune clearance phase (2014) (12)
- A Novel Estimation of the Impact of Treatment with Entecavir on Long-Term Mortality, Morbidity, and Health Care Costs of Chronic Hepatitis B in China. (2013) (12)
- Hepatitis C virus core antigen, an earlier and stronger predictor on sustained virological response in patients with genotype 1 HCV infection (2014) (12)
- Transfusion of multi-factors activated immune cells as a novel treatment for patients with chronic hepatitis B. (2006) (12)
- A Comparative Study of Patients’ Attitudes Toward Clinical Research in the United States and Urban and Rural China (2015) (11)
- Antibodies Targeting Novel Neutralizing Epitopes of Hepatitis C Virus Glycoprotein Preclude Genotype 2 Virus Infection (2015) (11)
- Female gender lost protective effect against disease progression in elderly patients with chronic hepatitis B (2016) (11)
- Expression of CIITA-related MHCII molecules in tumors linked to prognosis in hepatocellular carcinoma. (2009) (11)
- RFX5 promotes the progression of hepatocellular carcinoma through transcriptional activation of KDM4A (2020) (11)
- Peginterferon alfa-2b in the treatment of Chinese patients with HBeAg-positive chronic hepatitis B: a randomized trial. (2014) (11)
- Efficacy and Safety of All-oral, 12-week Ravidasvir Plus Ritonavir-boosted Danoprevir and Ribavirin in Treatment-naïve Noncirrhotic HCV Genotype 1 Patients: Results from a Phase 2/3 Clinical Trial in China (2019) (11)
- Efficacy and safety of a nanoparticle therapeutic vaccine in patients with chronic hepatitis B: A randomized clinical trial (2021) (11)
- Abnormal CD4 + T helper (Th) 1 cells and activated memory B cells are associated with type III asymptomatic mixed cryoglobulinemia in HCV infection (2015) (11)
- Association of central obesity with hepatocellular carcinoma in patients with chronic hepatitis B receiving antiviral therapy (2021) (10)
- Efficacy of switching to telbivudine in chronic hepatitis B patients treated previously with lamivudine (2011) (10)
- Etiological features of cirrhosis inpatients in Beijing, China (2013) (10)
- Dynamic metabonomic analysis of BALB/C mice with different outcomes after D‐galactosamine/lipopolysaccharide–induced fulminant hepatic failure (2008) (10)
- Efficacy and Safety of 12-week Interferon-based Danoprevir Regimen in Patients with Genotype 1 Chronic Hepatitis C (2019) (10)
- Effect of Upregulated DNA Replication and Sister Chromatid Cohesion 1 Expression on Proliferation and Prognosis in Hepatocellular Carcinoma (2018) (10)
- Liver fibrosis and hepatic stellate cells improvement of chronic hepatitis C patients by interferon-beta-1a with or without sustained viral response. (2009) (10)
- Differentiation of rat bone marrow stem cells in liver after partial hepatectomy. (2006) (10)
- Correlation analysis of hepatitis C virus core antigen and low viral loads: Can core antigen replace nucleic acid test? (2019) (10)
- Non-rigid Motion Correction for Ultrasound Localization Microscopy of the Liver in vivo (2019) (10)
- The functional evaluation of dendritic cell vaccines based on different hepatitis C virus nonstructural genes. (2007) (9)
- Dendritic cells from chronic hepatitis B patients can induce HBV antigen-specific T cell responses. (2004) (9)
- Genetic variability and characterization of non-structural region 5 of hepatitis C virus genome from Chinese patients (1998) (9)
- An Improved qFibrosis Algorithm for Precise Screening and Enrollment into Non-Alcoholic Steatohepatitis (NASH) Clinical Trials (2020) (9)
- INNO-LiPA HBV genotyping is highly consistent with direct sequencing and sensitive in detecting B/C mixed genotype infection in Chinese chronic hepatitis B patients and asymptomatic HBV carriers. (2010) (9)
- [Relationship between chronic hepatitis C and type II diabetes mellitus]. (2003) (9)
- Effects of Interferon-Alpha Treatment on the Incidence of Hyperglycemia in Chronic Hepatitis C Patients: A Systematic Review and Meta-Analysis (2012) (9)
- Recovery of natural killer cells is mainly in post-treatment period in chronic hepatitis C patients treated with sofosbuvir plus ledipasvir (2018) (9)
- Clinical features and survival in Chinese patients with hepatitis B e antigen‐negative hepatitis B virus‐related cirrhosis (2008) (9)
- Hepatitis E virus infection after haploidentical haematopoietic stem cell transplantation: incidence and clinical course (2018) (8)
- Simeprevir plus peginterferon/ribavirin for HCV genotype 1‐infected treatment‐naïve patients in China and South Korea (2016) (8)
- Fat Accumulation, Liver Fibrosis, and Metabolic Abnormalities in Chinese Patients With Moderate/Severe Versus Mild Hepatic Steatosis (2019) (8)
- Comparison of the efficacy of sofosbuvir plus ribavirin in Chinese patients with genotype 3a or 3b HCV infection (2019) (8)
- Baseline Characteristics and Treatment Patterns of the Patients Recruited to the China Registry of Hepatitis B (2019) (8)
- [Specific suppression in regulatory T cells by Foxp3 siRNA contributes to enhance the in vitro anti-tumor immune response in hepatocellular carcinoma patients]. (2009) (8)
- Evaluation of an antigen assay for diagnosing acute and chronic hepatitis E genotype 4 infection (2019) (8)
- Efficacy and safety of elbasvir/grazoprevir in treatment-naïve patients with chronic HCV GT 1, GT 4 and GT 6 infection (C-CORAL): a phase III randomized multinational clinical trial (2017) (8)
- Alcohol consumption analysis among patients with liver disease in China (2019) (7)
- Evaluation of the performance of the EIAgen HCV test for detection of hepatitis C virus infection. (2009) (7)
- HBsAg and HBeAg in the prediction of a clinical response to peginterferon α-2b therapy in Chinese HBeAg-positive patients (2016) (7)
- Cellular chromosome DNA interferes with fluorescence quantitative real‐time PCR detection of HBV DNA in culture medium (2008) (7)
- Drug resistance and HCV coinfection in former blood donors infected with HIV type 1 in China. (2011) (7)
- Plasma biomarker screening for liver fibrosis with the N-terminal isotope tagging strategy (2011) (7)
- [Relationship between the genotypes of hepatitis B virus and the severity of liver diseases]. (2003) (7)
- [Prevalence of nonalcoholic fatty liver disease in Asia]. (2013) (7)
- HBV infection involving in hepatic progenitor cells expansion in HBV-infected end-stage liver disease. (2009) (7)
- Influences on viral replication and sensitivity to GLS4, a HAP compound, of naturally occurring T109/V124 mutations in hepatitis B virus core protein (2017) (7)
- Dynamic changes of hepatitis B virus polymerase gene including YMDD motif in lamivudine-treated patients with chronic hepatitis B. (2008) (7)
- CD4+CXCR5+ T cells activate CD27+IgG+ B cells via IL-21 in patients with hepatitis C virus infection. (2016) (7)
- Risk factors for familial clustering of hepatitis C virus infection in a Chinese Han population: a cross-sectional study (2018) (7)
- Effect of interferon-gamma on hepatic stellate cells stimulated by acetaldehyde. (2008) (7)
- 2’,3’-Cyclic Nucleotide 3’-Phosphodiesterases Inhibit Hepatitis B Virus Replication (2013) (7)
- Natural history of chronic hepatitis B virus infection: What determines prognosis after cirrhotic decompensation? (2008) (6)
- [Comparison of hepatitis B virus serotype and genotype among HBsAg positive hepatitis B patients in a northern and a southern city of China]. (2003) (6)
- Daclatasvir plus asunaprevir in treatment-naïve patients with hepatitis C virus genotype 1b infection (2018) (6)
- Safety and efficacy of elbasvir/grazoprevir in Asian participants with hepatitis C virus genotypes 1 and 4 infection (2019) (6)
- Spectrum of Cerebrovascular Disease in Patients with Multiple Myeloma Undergoing Chemotherapy—Results of a Case Control Study (2016) (6)
- Survey of Nonalcoholic Fatty Liver Disease Knowledge, Nutrition, and Physical Activity Patterns Among the General Public in Beijing, China (2019) (6)
- Immunosuppressive treatment combined with nucleoside analog is superior to nucleoside analog only in the treatment of severe thrombocytopenia in patients with cirrhosis associated with hepatitis B in China: A multicenter, observational study (2015) (6)
- Relationship between interferon therapy and variability in nonstructural gene 5b of hepatitis C virus (1998) (6)
- An Assessment of Upper Limits of Normal for ALT and the Impact on Evaluating Natural Course of Chronic Hepatitis B Virus Infection in Chinese Children (2018) (6)
- [The effects of endothelial progenitor cell transplantation in carbon tetrachloride induced hepatic fibrosis rats]. (2007) (6)
- Impact of interleukin 28B polymorphisms on spontaneous clearance of hepatitis C virus infection: A meta‐analysis (2013) (6)
- [Inhibition of CD4+ CD25+ regulatory T cells in chronic hepatitis B patients]. (2008) (5)
- A hook-effect-free homogeneous light-initiated chemiluminescence assay: is it reliable for screening and the quantification of the hepatitis B surface antigen? (2020) (5)
- Pretreatment serum macrophage inflammatory protein (MIP)-1 levels predict sustained virological responses to re-treatment in patients with chronic hepatitis C virus infection. (2015) (5)
- Patient Education Improves Patient Knowledge and Acceptance on Antiviral Therapy of Hepatitis C in Rural China (2017) (5)
- Serum levels of preS antigen (HBpreSAg) in chronic hepatitis B virus infected patients (2007) (5)
- Histopathology and the predominantly progressive, indeterminate and predominately regressive score in hepatitis C virus patients after direct-acting antivirals therapy (2021) (5)
- Nationwide survey of specialist knowledge on current standard of care (Peg‐IFN/RBV) and barriers of care in chronic hepatitis C patients in China (2016) (5)
- Determination of the Human Antibody Response to the Neutralization Epitopes Encompassing Amino Acids 313–327 and 432–443 of Hepatitis C Virus E1E2 Glycoproteins (2013) (5)
- Profile of the VERSANT HCV genotype 2.0 assay (2018) (5)
- Obeticholic acid improves hepatic steatosis and inflammation by inhibiting NLRP3 inflammasome activation. (2017) (5)
- Temporal Changes in the Modes of Hepatitis C Virus Transmission in the USA and Northern China (2017) (5)
- 716 FIVE-YEAR TELBIVUDINE TREATMENT WITH EFFECTIVE VIRAL SUPPRESSION RESULTS IN RESOLUTION OF LIVER INFLAMMATION AND FIBROSIS REGRESSION IN PATIENTS WITH CHRONIC HEPATITIS B (2011) (5)
- Efficacy and safety of elbasvir/grazoprevir in treatment‐naive Chinese adults with hepatitis C virus infection: A randomized trial (2020) (5)
- [Clinical and virological course of dual infection by hepatitis B and C viruses in China]. (2003) (5)
- In vitro interactions between rat bone marrow-derived endothelial progenitor cells and hepatic stellate cells (2013) (5)
- Peginterferon Alfa-2a (40 kD) Stopping Rules in Chronic Hepatitis B: A Systematic Review and Meta-Analysis of Individual Participant Data (2019) (5)
- [Psychiatric disorders in patients with chronic rhinosinusitis and its associated factor analysis]. (2014) (5)
- Sustained serological and complete responses in HBeAg-positive patients treated with Peginterferon alfa-2b: a 6-year long-term follow-up of a multicenter, randomized, controlled trial in China (2019) (5)
- [The genetic polymorphism of melanoma-associated antigen 1 in Chinese normal donors and hepatoma patients]. (2004) (4)
- Effect of spleen operation on antiviral treatment in hepatitis C virus-related cirrhotic patients. (2014) (4)
- Prediction of Progression to Severe Stroke in Initially Diagnosed Anterior Circulation Ischemic Cerebral Infarction (2021) (4)
- [The frequency, phenotypes and functions of CD4+ CD25+ regulatory T cells in hepatocellular carcinoma patients]. (2007) (4)
- [Differentiation of bone marrow stem cells in rat hepatic fibrogenesis environment]. (2003) (4)
- Prevalence of abnormal glycometabolism in treatment‐naive patients with hepatitis C virus infection in a Chinese Han population (2015) (4)
- [High sustained virological response to optimized therapy for refractory chronic hepatitis C treatment-na(i)ve patients: a multicenter randomized study]. (2015) (4)
- Early predictive efficacy of core antigen on antiviral outcomes in genotype 1 hepatitis C virus infected patients (2015) (4)
- Comparison of clinical outcomes and impact of SVR in American and Chinese patients with chronic hepatitis C (2020) (4)
- Cryoglobulinemia is an independent factor negatively associated with sustained virological response in chronic hepatitis C patients. (2012) (4)
- [The prospective study of the clinical features and outcome of HBeAg-negative and HBeAg-positive cirrhosis in patients with chronic type B hepatitis]. (2007) (4)
- [Functions of cultured dendritic cells from patients with chronic hepatitis Beta decreased]. (2002) (4)
- Efficacy of pegylated interferon-alpha-2a plus ribavirin for patients aged at least 60 years with chronic hepatitis C. (2012) (4)
- [Correlation between interleukin-28B genetic polymorphisms and primary hepatocellular carcinoma]. (2012) (4)
- Effects of vitamin E on the proliferation and collagen synthesis of rat hepatic stellate cells treated with IL-2 or TNF-α (2003) (3)
- Pharyngeal constrictor muscle fatty change may contribute to obstructive sleep apnea-hypopnea syndrome: a prospective observational study (2016) (3)
- No association between IFNL3 (IL28B) genotype and response to peginterferon alfa-2a in HBeAg-positive or -negative chronic hepatitis B (2018) (3)
- Real-World Clinical Outcomes among Individuals with Chronic HCV Infection in China: CCgenos Study (2019) (3)
- 1339 IL28B GENETIC VARIANTS AND GENDER ARE ASSOCIATED WITH SPONTANEOUS CLEARANCE OF HEPATITIS C VIRUS INFECTION (2011) (3)
- [Clinical outcomes of women with transfusion-associated hepatitis C after 10-15 years follow-up]. (2004) (3)
- [Subcellular distribution and translocation of hepatitis B virus core protein in HepG2.2.15 cells]. (2008) (3)
- [Isolation, culture and multipotent differentiation of mesenchymal stem cells from human fetal livers]. (2004) (3)
- FOXP3 expression in FOXP3+ tumor cells promotes hepatocellular cells metastasis (2020) (3)
- Excision of preauricular sinus with abscess drainage in children. (2019) (3)
- [Hepatitis C recurrence after liver transplantation]. (2004) (3)
- A Comparative Study of Liver Disease Care in the USA and Urban and Rural China (2016) (3)
- [Etiologic characteristics of adult patients with community-acquired pneumonia in Beijing]. (2013) (3)
- [Study on norovirus GII.4/Sydney 2012 variant in China]. (2014) (3)
- [Isolation, identification and 16S rDNA phylogenetic analysis of Klebsiella pneumonia from diarrhea specimens]. (2008) (3)
- [Nine-year follow-up of hepatitis C virus infection in a rural area of Hebei province, China]. (2004) (3)
- [Effect of pegylated interferon beta-1a therapy on the liver fibrosis in chronic hepatitis C: a semi-quantitative analysis]. (2008) (3)
- HBsAg stimulates NKG2D receptor expression on natural killer cells and inhibits hepatitis C virus replication. (2018) (3)
- [Mechanism of transforming growth factor beta/Smad signaling and the relationship between its transduction and liver fibrosis]. (2005) (3)
- α-2-HS-glycoprotein is a potential marker predicting hepatitis B e antigen seroconversion in patients with chronic hepatitis B during treatment with pegylated interferon alfa-2b (2011) (3)
- P1272 : A comparative study of patient satisfaction with liver disease care in the United States and Urban and rural China (2015) (3)
- Hepatitis c virus genotype research by ABC programs of 5'-NCR restriction endocuclease digestion (2004) (3)
- [De novo autoimmune hepatitis after liver transplantation]. (2016) (3)
- China Registry of Hepatitis B (CR-HepB): Protocol and implementation of a nationwide hospital-based registry of hepatitis B (2020) (3)
- Association between CISH polymorphisms and spontaneous clearance of hepatitis B virus in hepatitis B extracellular antigen–positive patients during immune active phase (2014) (3)
- Hepatitis C Virus Genotype Analyses in Chronic Hepatitis C Patients and Individuals With Spontaneous Virus Clearance Using a Newly Developed Serotyping Assay (2017) (3)
- Correction: DCs Pulsed with Novel HLA-A2-Restricted CTL Epitopes against Hepatitis C Virus Induced a Broadly Reactive Anti-HCV-Specific T Lymphocyte Response (2012) (2)
- Association of interferon-γ-induced protein-10 serum levels with virological responses to PEG-interferon-based therapy in hepatitis C virus genotype 1 or 2 chronically infected Chinese patients (2014) (2)
- Primary leiomyosarcoma of the inferior vena cava (2010) (2)
- [Chinese recommendations for clinical practice guideline development]. (2015) (2)
- [The degree of HBV suppression with 24 week telbivudine- or lamivudine-treatment in hepatitis B patients predicts the efficacy of the treatment at week 52]. (2007) (2)
- Novel host genetic variations associated with spontaneous clearance of a single-source outbreak of HCV1b infections (2014) (2)
- [A multicenter, randomized, open-label study of the safety and effectiveness of pegylated interferon alpha 2b and interferon alpha 2b in treating HBeAg positive chronic hepatitis B patients]. (2006) (2)
- [Evaluation of health-related quality of life in chronic hepatitis C women patients]. (2004) (2)
- Impact of direct-acting antivirals on de novo occurrence of hepatocellular carcinoma in hepatitis C virus patients (2020) (2)
- [Therapeutic effect of levamisole plus HBV vaccine and dipyridamole on patients chronically infected by HBV with precore mutation]. (2004) (2)
- [SNaPshot technique for detection of single-nucleotide polymorphisms (SNPs) in HBV polymerase gene region of HBV gene]. (2005) (2)
- [Adenovirus mediated expression of interleukin 12 regulating hepatitis C virus E2 gene immunization-induced immune response]. (2004) (2)
- Treating chronic hepatitis B virus: Chinese physicians' awareness of the 2010 guidelines. (2016) (2)
- Genetic variation in FCER1A predicts peginterferon alfa‐2a‐induced hepatitis B surface antigen clearance in East Asian patients with chronic hepatitis B (2019) (2)
- [A study on viral gastroenteritis attributed to noroviruses in hospitals]. (2007) (2)
- Safety and efficacy of coblopasvir and sofosbuvir in patients with genotypes 1, 2, 3 and 6 HCV infections without or with compensated cirrhosis (2020) (2)
- [The efficacy and prognostic predictors of different treatment courses with pegylated interferon α-2a and ribavirin combination in recurrent chronic hepatitis C patients]. (2015) (2)
- [Granulocyte colony-stimulating factor-mobilized autologous bone marrow stem cells promote the liver regeneration of partial liver transplant: an experiment with rats]. (2005) (2)
- Abnormal phenotypic features of IgM+B cell subsets in patients with chronic hepatitis C virus infection. (2017) (2)
- [Hepatitis c virus genotype research by ABC programs of 5'-NCR restriction endonuclease digestion]. (2004) (2)
- [Investigating the inhibitory effects of interferon-alpha on the replication of hepatitis C virus replicon]. (2005) (2)
- Direct-acting Antiviral Regimens for Patients with Chronic Infection of Hepatitis C Virus Genotype 3 in China (2021) (2)
- [Relationship between the distribution of hepatitis B virus genotypes and clinical types of the disease in Han nationality hepatitis B patients in Xinjiang]. (2005) (2)
- Sequential combination therapy with IFN, rhIL-2 and therapeutic vaccine enhanced HBsAg loss in entecavir-suppressed CHB patients (the Endeavor study): an interim analysis (2017) (2)
- Effects of vitamin E on the proliferation and collagen synthesis of rat hepatic stellate cells treated with IL-2 or TNF-alpha. (2003) (1)
- Association of FOXP3 Gene Polymorphism with Chronic Hepatitis B in Chinese Population (2012) (1)
- Hepatitis C virus nonstructural protein specific T cells are associated with virological responses to combination therapy in chronic HCV patients (2012) (1)
- [Cyclosporine A improves the nuclear entry of hepatitis B virus core protein in HepG2.2.15 cells]. (2007) (1)
- [Management algorithm for prevention of mother-to-child transmission of hepatitis B virus (2021)]. (2021) (1)
- [Introduction and comments on AASLD practice guidelines: diagnosis and treatment of acute liver failure and assessment of liver transplant patients]. (2006) (1)
- Genetic Variation in FCER1A Gene Predicts Sustained HBsAg Clearance in East-Asian Patients Treated with Pegylated Interferon Alfa-2a (40kd): The “Peg-Be-Yond” Study (2016) (1)
- [Dapsone syndrome: a case report]. (2006) (1)
- [Analysis and state of HCV genotype 6a infection]. (2006) (1)
- [ISGF3, a critical factor of the IFN-alpha pathway in the antiviral action of HBV]. (2005) (1)
- [The distribution of hepatitis C virus genotype 1a in Yanbian area]. (2007) (1)
- [Inhibitory effect of interferon-beta on the activation of LX-2 and rHSC-99 hepatic stellate cells in culture]. (2006) (1)
- Correction: Spectrum of Cerebrovascular Disease in Patients with Multiple Myeloma Undergoing Chemotherapy—Results of a Case Control Study (2016) (1)
- [Ten years outcome observation of infants with hepatitis C virus mother to infant transmission]. (2003) (1)
- Molecular Epidemiology of HCV in Asia (2013) (1)
- [High replicated hepatitis B virus induces apoptosis of hepatocytes]. (2008) (1)
- [Relationship between the quantities of peripheral dendritic cells and of serum HBV DNA and the inflammatory reaction levels in the liver]. (2005) (1)
- [YVDD is the primary symbol of gene mutation in hepatitis B patients treated with lamivudine]. (2005) (1)
- Randomized, observational study of long-term entecavir treatment versus other standard of care nucleos (t) ide analog therapy in nucleos(t)ide-naïve patients with chronic hepatitis B from a ‘real-world’ clinical practice setting in china (2013) (1)
- [Utilization of Uracil-DNA glycosylase for combining reverse transcription and anti-contamination with polymerase chain reaction in hepatitis C virus]. (2007) (1)
- Clinical, immunological and pathological characterization of autoimmune hepatitis: an analysis of 142 cases (2006) (1)
- Efficacy and safety of combination therapy with interferon and immunomodulators in entecavir-suppressed chronic hepatitis B patients (the endeavor study) (2018) (1)
- [The direct antiviral effect of interferon-gamma on hepatitis C virus replicon]. (2006) (1)
- Mo1399 - High Efficacy and Substantial Improvement of Health-Related Quality of Life (HRQL) in Chinese Patients with Hepatitis C Virus (HCV) Infection Treated with Ledipasvir and Sofosbuvir (LDV/SOF) (2018) (1)
- FOXP3 gene polymorphism is associated with hepatitis B-related hepatocellular carcinoma in China (2013) (1)
- Cytokines expression in the membranous tissue and organized thrombi in membranous obstruction of Budd Chiari syndrome (2008) (1)
- Dramatic response of CTNNB1 and VEGFR-2 mutant temporal bone squamous cell carcinoma to bevacizumab in combination with pemetrexed (2017) (1)
- Efficacy and Safety of All-oral Emitasvir and Sofosbuvir in Patients with Genotype 1b HCV Infections without Cirrhosis (2020) (1)
- Dramatic response of CTNNB1 and VEGFR-2 mutant temporal bone squamous cell carcinoma to bevacizumab in combination with pemetrexed. (2017) (1)
- [Analysis of prognosis of patients with decompensated liver cirrhosis using the criterion of the Model of End-Stage Liver Disease]. (2005) (1)
- Phase I evaluation of lenvatinib and weekly paclitaxel in patients with recurrent endometrial, ovarian, fallopian tube, or primary peritoneal cancer (2019) (1)
- Efficacy and safety of yimitasvir phospha combined with sofosbuvir in patients with chronic hepatitis C virus infection (2019) (1)
- Consensus on the diagnosis and treatment of cholestatic liver diseases (2015, China) (2016) (1)
- [Etiological study on sporadic viral gastroenteritis among adult in Beijing]. (2008) (1)
- [277] ENHANCEMENT OF VACCINE-MEDIATED ANTI-TUMOR IMMUNITY IN PATIENTS WITH HEPATOCELLULAR CARCINOMA AFTER DEPLETION OF REGULATORY T CELLS (2007) (0)
- Clinical application of modified incision and sternocleidomastoid muscle flap in surgery of parotid gland tumors (2011) (0)
- Examination paper analysis of infectious disease from eight-year progrm medical students (2011) (0)
- [Construction of eukaryotic expression vector expressing hepatitis B virus HBsAg and EGFP fusion protein and establishment of stable transfected Chang Liver cell line]. (2005) (0)
- Amino Acid Sequence Analysis in Patients with Chronic HCV Genotype 1B Infection during Pegylated Interferon-α2A and Ribavirin Therapy (2014) (0)
- Surgery for lower-extremity arteriosclerotic occlusive disease (2008) (0)
- Immunosuppressive Treatment Combined with Nucleoside Analogues Is Superior to Nucleoside Analogues Alone in the Treatment of Severe Thrombocytopenia in Patients with Cirrhosis-Associated with Hepatitis B in China: A Multicenter, Observational Study (2014) (0)
- Clinical analysis of erythrodermic drug eruption complicated with aspergillosis of vocal ford (2008) (0)
- STUDY ON THE DETECTION OF HP IN MOUSE GASTRIC MUCOUS MEMBRANE BY PCR (2001) (0)
- Experiences in carotid-artery stenting with the use of filter in 35 cases (2009) (0)
- Exome capture and allinone sequencing to identify potential single nucleotide polymorphisms associated with spontaneous hepatitis C virus clearance (2013) (0)
- PPPDE1 promotes hepatocellular carcinoma development by negatively regulate p53 and apoptosis (2018) (0)
- Clinical anlysis of 118 cases of female infertility diagnosed by hysterosalpingography and hysteroscopy combined with laparoscopy (2012) (0)
- Mo1047 A Comparative Study of Decision Making Preferences in Patients With Liver Disease in the United States and Urban and Rural China (2015) (0)
- THU-243-Occult hepatitis B virus infection after haploidentical haematopoietic stem cell transplantation patients: incidence and characterization of HBV pres/s gene mutations (2019) (0)
- FOXP3 gene polymorphisms and hepatocellular carcinoma (2012) (0)
- [Expression of MAGE-A1 in human hepatoma cell lines associated with genic hypomethylation]. (2005) (0)
- Stem cell research and its prospects for liver disease treatment. (2004) (0)
- THU-450-RFX5 promotes hepatocellular carcinoma progression via transcriptional activation of YWHAQ (2019) (0)
- P0551 : The CRISPR/Cas9 system being as a cutter for covalently closed circular dna of hepatitis B virus (2015) (0)
- [Amplification of hepatitis C virus 5' untranslated region gene by RACE and its secondary structure analysis]. (2002) (0)
- [Dendritic cells originated from the peripheral blood in chronic hepatitis B patients can induce specific T cell immune response]. (2003) (0)
- SAT-267-Occult hepatitis C in immunocompetent patients who have achieved sustained viral response is associated with persistent histological abnormality (2019) (0)
- HBsAg and HBeAg in the prediction of a clinical response to peginterferon α-2b therapy in Chinese HBeAg-positive patients (2016) (0)
- The hepatitis C virus 5' untranslated region gene amplified by rapid amplification of cDNA ends and its secondary structure. (2002) (0)
- [Construction of recombinant replication competent plasmids containing HBV genome with mutations of precore and basic core promoter]. (2004) (0)
- Observation on the effect of coagulants for the patients with COPD combined upper GI bleeding (2007) (0)
- The tracability and uniform unit of hepatitis C virus RNA quantification by domestic made real-time fluorescence quantitative PCR method (2010) (0)
- THU-192-All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive noncirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china (2019) (0)
- Hepatitis E Virus Infection after Haploidentical Hematopoietic Stem Cell Transplantation:Incidence and Clinical Course (2018) (0)
- [Present situation of hepatitis C virus antiviral therapy and application prospects of small molecule drugs in our country]. (2013) (0)
- [Dynamic variations of hepatitis B virus polymerase gene in lamivudine-treated hepatitis B patients]. (2006) (0)
- Endovascular repair for distal intima tears in Debakey type III dissecting aneurysm (2012) (0)
- [How to improve the efficacy of antiviral therapy on patients with hepatitis C related cirrhosis]. (2013) (0)
- [Stem cells therapy and severe acute exacerbation of chronic hepatitis B]. (2010) (0)
- [Virus spectrum features of adult influenza-like fever in outpatients]. (2013) (0)
- [Effect of glia maturation factor beta on the activation of hepatic stellate cells and on liver fibrosis]. (2007) (0)
- SAT-237-Histological improvement of hepatitis C virus patients after achieving sustained virological response with direct-acting antivirals (2019) (0)
- [435] INTRACELLULAR LOCATION AND SHIFT OF HEPATITIS B VIRUS CORE PROTEIN IN HepG2.2.15 CELL-LINE (2007) (0)
- [The effect of cryoglobulinemia on the antiviral therapy in patients with chronic hepatitis C]. (2011) (0)
- Identification of differential HLA-binding peptide between two hepatoma cell lines HepG2 and HepG2.2.15 (2008) (0)
- Plasticbell circumcision for 1000 children with phimosis (2004) (0)
- [Using RNA interference to treat hepatitis virus: hope for future development]. (2004) (0)
- MYL6B, a myosin light chain, promotes MDM2-mediated p53 degradation and drives HCC development (2018) (0)
- Amplifying, cloning and sequence analyzing the gene of full-length NS4 region of genotype 2a/III hepatitis C virus by using long nested PCR (2002) (0)
- The effect of endothelial progenitor cell transplantation on liver cirrhosis in rats (2009) (0)
- [Chronic hepatitis C: controversies, challenges and future goals]. (2011) (0)
- The etiology of genital ulcer disease and its relationship to HIV infection among patients attending sexually transmitted disease clinics (2005) (0)
- Evaluation of cross-reactive antibody response to HVR1 in chronic hepatitis C. (2010) (0)
- MSCT and MRI in diagnosis of giant uterine leiomyomas (2013) (0)
- Thoracic endovascular aortic repair for chronic type B aortic dissection in 30 patients (2013) (0)
- [The use of nucleotide analogues in treating patients with chronic hepatitis B]. (2006) (0)
- Role of NK Cell in the Pathogenesis of Urticaria (2007) (0)
- Peritumoural neutrophils negatively regulate adaptive immunity via the PD-L1/PD-1 signalling pathway in hepatocellular carcinoma (2015) (0)
- [Subgenomic replicon model of hepatitis C virus and it's application]. (2005) (0)
- Abstract 4394: Utilizing pharmacokinetics and toxicity data in the translational drug interaction knowledgebase to bridge the phase I cancer drug combination studies (2020) (0)
- PPPDE1, a deubiquitinating enzyme, is a novel onco-gene in Hepatocellular Carcinoma (2012) (0)
- Cleavage of intracellular hepatitis B virus genomeby using of CRISPR/Cas9 (2016) (0)
- [Effect of antiviral therapy on the prognosis of patients with chronic hepatitis B-related cirrhosis]. (2013) (0)
- Effect of Treatment of Syphilis During Pregnancy and Pre-pregnancy on Pregnant Outcome (2006) (0)
- Detection of GB Virus C/Hepatitis G Virus RNA by Reverse-Transcription Polymerase Chain Reaction (1999) (0)
- Hepatitis B virus induces expression of connective tissue growth factor and transforming growth factor-β1 in hepatic stellate cells (2008) (0)
- [Cloning and sequence analysis of E1, E2/NS1 region of genotype 2a hepatitis C virus genome]. (2003) (0)
- [Natural history of hepatitis C]. (2004) (0)
- [Transfusion of activated immune cells induced fluctuations of HCV titer without mutations in hepatitis C virus core and E2 region CTL epitopes]. (2002) (0)
- Glecaprevir/Pibrentasvir to Treat Chronic Hepatitis C Virus Infection in Asia: Two Multicentre, Phase 3 Studies – A Randomised, Double-Blind Study (VOYAGE-1) and an Open-Label, Single-Arm Study (VOYAGE-2) (2020) (0)
- SAT-495-Incidence and risk factors of hepatocellular carcinoma in patients with hepatitis C in China and the US (2019) (0)
- [Clinical outcomes of 283 patients of transfusion-related hepatitis C in the northern areas of China]. (2004) (0)
- Abnormal CD4 + T helper (Th) 1 cells and activated memory B cells are associated with type III asymptomatic mixed cryoglobulinemia in HCV infection (2015) (0)
- The effect of mutation of hepatitis B virus core protein dimer interface domain related to nucleocapsid formation on HBV replication (2010) (0)
- Clinical Observation of Phakic Posterior Chamber Intraocular Lens Implantation for High Myopia Correction (2012) (0)
- [Focusing on hepatitis C research]. (2006) (0)
- Abstract 20: Mutation profiling reveals distinct signatures in hypopharyngeal squamous cell carcinoma (2016) (0)
- [Thirteen to fourteen years' follow-up of patients with hepatitis C]. (2005) (0)
- Impact of hepatoprotective drugs on the performance of APRI for diagnosing liver fibrosis in chronic hepatitis B (2019) (0)
- [Prospect of internal medicine associatied with liver transplantation: update in 2008.]. (2009) (0)
- Resistance mutation during anti-HBV and anti-HCV treatment:question and strategy (2013) (0)
- [Congenital preauricular fistula infection: a histopathology observation]. (2014) (0)
- [The dynamic changes of hepatitis C virus quasispecies during natural infections]. (2006) (0)
- [Relative stasis of hepatitis C virus quasispecies in natural duration]. (2003) (0)
- 354 REGULATORY T CELLS INVOLVED IN IMMUNOPATHOGENESIS FROM CHRONIC HEPATITIS B PROGRESSED TO HEPATOCELLULAR CARCINOMA (2008) (0)
- [Focusing on the markers for monitoring and antiviral therapy in chronic hepatitis B virus infection]. (2006) (0)
- Evaluation of the performance of a DNA microarray method for detecting HBV mutations conferring antiviral resistance to lamivudine and adefovir (2010) (0)
- Correlation between anti-mitochondrial antibodies and clinical serological and cirrhotic markers of primary biliary cholangitis (2020) (0)
- Multiplex Fluorescent Real-time PCR for Detection and Typing of Herpes Simplex Virus (2004) (0)
- Progress and challenges in the laboratory diagnosis of hepatitis C virus (2008) (0)
- 811 Hepatitis B Knowledge and Stigma in China (2016) (0)
- [Quantitative determination for HBeAg: in clinical practice and potential future applications]. (2011) (0)
- Correlation between genotype and HCV RNA in chronic hepatitis C patients (2011) (0)
- Trend of clinical diagnosis of hepatitis B virus: quantity and standardization (2009) (0)
- [Stem cell sources of hepatic cells]. (2003) (0)
- qfibrosis scoring for different animal models with liver fibrosis induced by Taa, Ccl4 or Bdl : 782 (2015) (0)
- [442] INHIBITORY EFFECTS OF VARIOUS TYPE IFN ON THE HCVRNA REPLICATION OF HCV REPLICON CELLS (2007) (0)
- [Role of pegylated-interferon in the treatment of hepatitis C in Chinese patients]. (2015) (0)
- 486 IDENTIFICATION OF A NOVEL MOLECULAR CANDIDATE-GLIA MATURATION FACTOR-BETA FOR ACTIVATION OF HEPATIC STELLATE CELLS (2008) (0)
- [Genotpye of HBV: research progress and clinical direction]. (2005) (0)
- SAT-257-Incidence and predictors of liver outcomes in chronic hepatitis C patients: Comparison of an American and a Chinese cohort (2019) (0)
- [Outcomes of liver transplantation in different liver diseases and their impact factors]. (2008) (0)
- [Characteristics of resting state functional magnetic resonance imaging in tinnitus patients with different degrees of affective disorder]. (2020) (0)
- [Screening of target autoantigen in hepatocytes from hepatocyte cDNA library by phage display technique]. (2006) (0)
- Clinical Analysis of 8 Cases of Pyoderma Gangrenosum (2012) (0)
- [The difference of IL-28B polymorphisms between hepatitis C patients with and without cryoglobulinemia]. (2013) (0)
- Serum lipid level of patients with branch retinal vein occlusion (2013) (0)
- Relationship between HCV RNA quantities and HCV genotypes and the outcome of patients with posttransfusion hepatitis C virus infection (2004) (0)
- Evaluation of INNO-LiPA in detection of HBV drug resistance mutation (2009) (0)
- [Clinical and histological features of the patients with hepatitis B recurrence after allo-genetic hemopoietic stem cell transplantation]. (2004) (0)
- [Stem cells for treating liver diseases: the current situation and possibilities in the near future]. (2007) (0)
- [Health-related quality of life of chronic hepatitis C patients]. (2006) (0)
- [What's new in 2014 for treatment of hepatitis C]. (2015) (0)
- 920 A NOVEL HEPATITIS B VIRUS MUTATION WITH RESISTANCE TO ADEFOVIR DIPIVOXIL IN PATIENTS WITH CHRONIC HEPATITIS B (2009) (0)
- Correlation between the imaging manifestations of cerebellar infarction and the clinical characteristics of patients: a retrospective analysis (2021) (0)
- Covered stent in endovascular treatment of aortoiliac occlusive disease (2013) (0)
- [A study on stem cell mobilization after partial liver transplantation in rats]. (2005) (0)
- PPPDE1 is a deubiquitinase that promotes HCC develop-ment by stabilizing a 25kd MDM2 N terminal fragmentand subsequently suppressing the p53 pathway (2015) (0)
- [An introduction of the researches on hepatitis C virus infection from the 46th EASL annual conference]. (2011) (0)
- [Observational research is an important accompaniment to randomized and controlled clinical studies]. (2015) (0)
- [The potential role of liver stem cells in liver disease treatment]. (2005) (0)
- [Interferon caused dysfunction of thyroid in chronic hepatitis C patient: a case report]. (2010) (0)
- [Congenital preauricular fistula infection: a histopathology observation]. (2014) (0)
- [A report from the 12th Symposium on Viral Hepatitis and Liver Diseases]. (2005) (0)
- [Sequential variation in 3' untranslated region of hepatitis C virus in mainland of China]. (2002) (0)
- [Autologous adoptive immunotherapy without destruction of infected cells during the treatment of chronic hepatitis B]. (2003) (0)
- In vitro interactions between rat bone marrow-derived endothelial progenitor cells and hepatic stellate cells (2013) (0)
- Association of ATP-Binding Cassette Transporter (ABC) Gene Polymorphisms with Viral Load in Patients with Genotype 1 Hepatitis C Virus Infection. (2016) (0)
- [Liver transplantation: challenge today]. (2012) (0)
- [Impaired non-viral specific immune function of dendritic cell does not interfere with clearance and cytotoxic T lymphocyte response to HBV or HCV]. (2004) (0)
- [Comparisons of the characteristics and mechanisms of HBV replication in QSG-7701 and HepG2 cell lines]. (2007) (0)
- Reply (2020) (0)
- Comparison of two HBV DNA detection kits (2011) (0)
- Thirteen to twenty-seven-year follow-up of patients with hepatitis C while transfusing or donating plasma. (2007) (0)
- Factors related to the therapeutic efficacy of(131)I in Graves' disease (2011) (0)
- [Ultrastructure of the upper airway skeletal muscle in patients with obstructive sleep apnea hypopnea syndrome patients]. (2013) (0)
- The use of chimney teclmique in endovascular repair of type III aortic dissection and abdominal aortic aneurysm (2012) (0)
- [What is new in 2012 on hepatitis C]. (2013) (0)
- Increased expression of Collagen I and Collagen III induced by HBV in hepatic stellate cells (2008) (0)
- [Treatment for chronic hepatitis C, more opportunity, more challenge]. (2009) (0)
- [Current and future perspectives of chronic hepatitis C virus infection in China]. (2014) (0)
- AIDS-associated mycoplasmas infections in patients with nongonococcal urethritis and mucopurulent cervicitis (2002) (0)
- Clinical advances on danoprevir and triple therapy of danoprevir with Peg IFN and ribavirin regimen in treatment of chronic hepatitis C (2018) (0)
- [A study on the mutation of P gene region including YMDD motif in hepatitis B virus]. (2004) (0)
- Abdominal aortic balloon occlusion during the resection of pelvic tumors and management for related vascular complications (2012) (0)
- [Lamivudine treatment of patients with decompensated HBV cirrhosis and mutation in YMDD motif]. (2005) (0)
- 522 THE ROLE OF ENDOTHELIAL PROGENITOR CELLS TRANSPLANTED IN RATS WITH HEPATIC CIRRHOSIS (2008) (0)
- Direct-acting antiviral agents in the management of chronic hepatitis C virus in China: factors and considerations (2018) (0)
This paper list is powered by the following services:
